Setmelanotide Weekly as Safe and Effective as Daily Use, Trial Data Suggest
A new weekly formulation of setmelanotide, Rhythm Pharmaceuticals’ lead treatment candidate for rare genetic obesity disorders, is as safe and effective in promoting weight loss as the daily formulation, interim data from a Phase 2 trial show. The findings, collected from people with obesity but without these genetic…